2017 MAP Conference | Treatment of MAP in a patient with Crohn’s Disease Followed by Disease Resolution
Dr. Shoor Vir Singh is a Principal Scientist at the Indian Council of Agricultural Research. He was unable to present at the 2017 MAP Conference due to a prior commitment, but has kindly provided his presentation materials. The presentation begins with an overview of MAP in India, and progresses to a detailed case study of a Crohn’s disease patient whose stool sample tested positive for Indian bison type MAP. After a year of antibiotic treatment, his Crohn’s disease symptoms had abated and MAP testing was negative. The antibiotic treatment regimen is detailed in Dr. Singh’s presentation. The final portion of the presentation describes treatment and control strategies for MAP in India, including an indigenous bison-type vaccine that is now available.
“Understanding Crohn’s disease is not rocket science — It is far more complex.” In this presentation, John Aitken from 
Dr. Bach is an Adjunct Professor in the Division of Infectious Diseases at the University of British Columbia in Vancouver, Canada. His research interests include understanding how pathogenic microorganisms successfully infect and multiply in humans, nanomedicine and antibody design. In his presentation, Dr. Bach discusses how MAP can survive in the macrophage and levels of antibodies found in Crohn’s patients vs. healthy control. Antibody levels are measured before and after traditional Crohn’s disease treatments are administered.
Dr. Chamberlin is a gastroenterologist at the San Antonio Military Medical Center in Texas. In his talk, he presents evidence of healing in Crohn’s disease patients treated with antibiotics. He also reviews some of the literature on antibiotic treatment in Crohn’s disease and discusses the flawed Selby antibiotic trial. “Do antibiotics have a positive effect on Crohn’s disease? Absolutely.”